Bank Julius Baer & Co. Ltd Zurich Acquires 40,704 Shares of Intuitive Surgical, Inc. (NASDAQ:ISRG)

Bank Julius Baer & Co. Ltd Zurich increased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 5.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 833,606 shares of the medical equipment provider’s stock after purchasing an additional 40,704 shares during the quarter. Intuitive Surgical makes up 1.4% of Bank Julius Baer & Co. Ltd Zurich’s portfolio, making the stock its 16th biggest holding. Bank Julius Baer & Co. Ltd Zurich owned approximately 0.23% of Intuitive Surgical worth $466,620,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds also recently added to or reduced their stakes in ISRG. Berbice Capital Management LLC purchased a new stake in Intuitive Surgical during the 4th quarter valued at approximately $26,000. BankPlus Trust Department purchased a new position in shares of Intuitive Surgical in the fourth quarter worth $28,000. Kohmann Bosshard Financial Services LLC bought a new position in shares of Intuitive Surgical during the fourth quarter worth $31,000. MidAtlantic Capital Management Inc. purchased a new position in Intuitive Surgical during the third quarter valued at $33,000. Finally, Decker Retirement Planning Inc. bought a new stake in Intuitive Surgical in the 4th quarter valued at $36,000. Institutional investors own 83.64% of the company’s stock.

Insider Activity

In other Intuitive Surgical news, EVP Myriam Curet sold 408 shares of the business’s stock in a transaction dated Tuesday, February 11th. The shares were sold at an average price of $589.75, for a total value of $240,618.00. Following the completion of the transaction, the executive vice president now directly owns 353 shares in the company, valued at approximately $208,181.75. The trade was a 53.61 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CFO Jamie Samath sold 270 shares of the firm’s stock in a transaction dated Tuesday, December 10th. The shares were sold at an average price of $540.15, for a total transaction of $145,840.50. Following the completion of the sale, the chief financial officer now owns 8,757 shares in the company, valued at $4,730,093.55. This represents a 2.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders sold 13,579 shares of company stock worth $7,756,844. 0.90% of the stock is currently owned by corporate insiders.

Intuitive Surgical Price Performance

NASDAQ:ISRG opened at $518.26 on Friday. Intuitive Surgical, Inc. has a 1-year low of $364.17 and a 1-year high of $616.00. The company has a 50-day moving average of $571.36 and a 200 day moving average of $531.20. The firm has a market cap of $184.59 billion, a PE ratio of 80.85, a price-to-earnings-growth ratio of 5.85 and a beta of 1.43.

Analyst Upgrades and Downgrades

Several research firms have commented on ISRG. Raymond James increased their price objective on shares of Intuitive Surgical from $560.00 to $688.00 and gave the company an “outperform” rating in a report on Friday, January 24th. BTIG Research upped their price objective on Intuitive Surgical from $535.00 to $561.00 and gave the stock a “buy” rating in a report on Tuesday, November 26th. Jefferies Financial Group raised their target price on shares of Intuitive Surgical from $475.00 to $575.00 in a report on Monday, January 27th. Evercore ISI upped their price target on shares of Intuitive Surgical from $490.00 to $530.00 in a research note on Monday, January 27th. Finally, Wells Fargo & Company lifted their price objective on shares of Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday, January 24th. One research analyst has rated the stock with a sell rating, four have assigned a hold rating and sixteen have assigned a buy rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $613.10.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.